Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
NRC 
National Research Corp (NRC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/05/2025: NRC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -28.59% | Avg. Invested days 23 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/05/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 379.83M USD | Price to earnings Ratio 16.34 | 1Y Target Price - |
Price to earnings Ratio 16.34 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.41 | 52 Weeks Range 9.68 - 26.32 | Updated Date 06/29/2025 |
52 Weeks Range 9.68 - 26.32 | Updated Date 06/29/2025 | ||
Dividends yield (FY) 2.88% | Basic EPS (TTM) 1.02 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 17.14% | Operating Margin (TTM) 25.62% |
Management Effectiveness
Return on Assets (TTM) 17.13% | Return on Equity (TTM) 72.69% |
Valuation
Trailing PE 16.34 | Forward PE - | Enterprise Value 442535968 | Price to Sales(TTM) 2.69 |
Enterprise Value 442535968 | Price to Sales(TTM) 2.69 | ||
Enterprise Value to Revenue 3.13 | Enterprise Value to EBITDA 10.73 | Shares Outstanding 22785400 | Shares Floating 13270457 |
Shares Outstanding 22785400 | Shares Floating 13270457 | ||
Percent Insiders 46.97 | Percent Institutions 51.25 |
Upturn AI SWOT
National Research Corp
Company Overview
History and Background
National Research Corporation was founded in 1981. It initially focused on providing healthcare market research and evolved to offer a broader suite of solutions for improving patient experience and engagement. The company has grown through organic expansion and strategic acquisitions.
Core Business Areas
- Experience Solutions: This segment provides patient and resident experience measurement and improvement solutions to healthcare organizations.
- Governance Solutions: This segment offers solutions for board governance, strategic planning, and performance improvement for healthcare systems.
- Strategic Market Insights: This segment provides market research and analytics to healthcare providers to inform strategic decisions.
Leadership and Structure
The leadership team includes Michael Hays (CEO). The organizational structure includes functional departments such as sales, marketing, product development, and finance.
Top Products and Market Share
Key Offerings
- Experience Measurement Platform: This platform gathers patient feedback and provides insights to improve the patient experience. Market share data is difficult to pinpoint precisely as it's bundled into larger market research data. Competitors include Press Ganey, Gallup, and Medallia.
- Patient Experience Surveys: Surveys tailored for healthcare providers to gather patient feedback regarding their experience. Specific revenue figures are not publicly available. Competitors include Press Ganey, and Advisory Board.
- Governance & Strategic Planning Solutions: Offerings such as performance dashboards and decision support tools. Specific market share data is not publicly available. Competitors include Kaufman Hall, and Strata Decision Technology.
Market Dynamics
Industry Overview
The healthcare market research industry is growing, driven by increasing emphasis on patient satisfaction, value-based care, and regulatory compliance. There is a growing focus on consumer-centric healthcare.
Positioning
National Research Corporation is positioned as a provider of comprehensive patient experience and governance solutions for the healthcare industry. Their competitive advantage lies in its integrated platform and expertise in healthcare market research.
Total Addressable Market (TAM)
The TAM for healthcare market research and consulting is estimated to be in the billions of dollars. National Research Corp is well positioned to capture a significant share of this market with its established presence and diverse service offerings.
Upturn SWOT Analysis
Strengths
- Established brand reputation
- Strong client relationships in healthcare
- Comprehensive suite of solutions
- Data-driven insights and analytics
Weaknesses
- Reliance on the healthcare industry
- Potential for competition from larger consulting firms
- Dependence on accuracy of data gathering and analysis
- Slower growth compared to tech-based competitors.
Opportunities
- Expansion into new healthcare markets
- Development of new product offerings
- Strategic acquisitions
- Leveraging AI and machine learning for enhanced analytics
Threats
- Economic downturns impacting healthcare budgets
- Increased competition from new entrants
- Changes in healthcare regulations
- Data security breaches
Competitors and Market Share
Key Competitors
- PGND
Competitive Landscape
National Research Corporation's advantages include its established brand and focus on the healthcare industry. Disadvantages include competition from larger consulting firms and reliance on the healthcare industry.
Major Acquisitions
Press Ganey Associates (example, data is not real)
- Year: 2017
- Acquisition Price (USD millions): 250
- Strategic Rationale: The hypothetical acquisition would enhance market share and expand service offerings in patient experience.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been steady, driven by demand for patient experience and governance solutions. Growth rates vary year to year.
Future Projections: Future projections are based on analyst estimates and company guidance. Growth is expected to continue at a moderate pace.
Recent Initiatives: Recent initiatives include expanding service offerings and investing in technology to enhance data analytics capabilities.
Summary
National Research Corporation is a reputable player in the healthcare market research and patient experience solutions industry. The company benefits from strong client relationships and a comprehensive suite of services. However, it faces competition from larger firms and is reliant on the healthcare sector. Expansion into new markets and strategic acquisitions could fuel future growth.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Market Research Reports
- Analyst Reports
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Market conditions and company performance can change rapidly. Please do your own research before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About National Research Corp
Exchange NASDAQ | Headquaters Lincoln, NE, United States | ||
IPO Launch date 1997-10-10 | CEO & Director Mr. Trent Green | ||
Sector Healthcare | Industry Health Information Services | Full time employees 368 | Website https://www.nrchealth.com |
Full time employees 368 | Website https://www.nrchealth.com | ||
National Research Corporation provides analytics and insights that facilitate measurement and improvement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company also offers marketing experience solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools through a multi-mode digital platform. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; employee experience solutions that give care teams information, tools and support needed to create engagement and open communication throughout the employee lifecycle; and consumer experience solutions which capture feedback across the healthcare journey, drive choice to build volume, and co-design experiences and services through community insights. Additionally, the company offers Huey AI, an AI engine for Human Understanding that serves as a healthcare experience management companion; and governance solutions for not-for-profit health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.